Haematologica (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435, www.haematologica.org) publishes peer-reviewed papers across all areas of experimental and clinical hematology. The journal is owned by the Ferrata Storti Foundation, a non-profit organization, and serves the scientific community with strict adherence to the principles of open access publishing (www.doaj.org). In addition, the journal makes every paper published immediately available in PubMed Central (PMC), the US National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature. In the present study, we evaluated Th17 cells in the peripheral blood of ITP patients and healthy subjects by using a panel of monoclonal antibodies according to Cosmi et al. (9 (2) . Six patients were studied at diagnosis, 7 had persistent and 2 chronic ITP. At the time of sample collection, patients were off-treatment by at least three months and none of the patients had been previously splenectomized. The median platelet count was 50x10 9 /L (range 8-99).
Fifteen healthy subjects were also studied (6 men and 9 women; median age 40). All subjects provided written informed consent.
Mononuclear cells (MNCs), anticoagulated with ethylene diamine tetraacetic acid, were isolated from peripheral blood of healthy individuals and ITP patients via density gradient centrifugation using Ficoll-Hypaque (Cedarlane-Celbio, Milan, Italy). Immunofluorescence was performed using the following monoclonal antibodies: APC-conjugated anti-CD45, PerCP-conjugated anti-CD4, PEconjugated anti-CD161, FITC-conjugated anti-CD196. All from BD Pharmingen (Milan, Italy).
Immediately after washing with phosphate buffered saline (PBS), cells were analyzed by using a BD FACSCanto II equipment (Bekton Dickinson, Milan, Italy) and were gated for lymphocytes on the basis of their CD45 and side scatter profile (CD45 bright and SSC low). A minimum of 10.000 events of the MNC fraction was collected. Absolute cell counts were assessed using a "dual platform" technique where the flow cytometer provides the cell percentages and the hematology analyzer provides the absolute white blood cell count. Differences between groups were compared using the non parametric Wilcoxon rank sum test. Spearman rank correlation test was used for correlation analysis. P values <0.05 were considered statistically significant.
As shown in Figure 1A and B, the mean percentage ± standard deviation and the mean absolute number ± standard deviation of circulating Th17 cells were comparable between ITP patients (12.22±4.82%; 107±72 cells/µL) and controls (11.88±4.95%; 93±39 cells/µL) (p=NS). In addition, according with Guo et al (8) , there was no significant correlation between the number of Th17 cells and the platelet count in ITP patients. Thus, our results do not suggest that ITP is associated with a significant difference in the number of circulating Th17 cells as compared to healthy individuals.
Consistently, previous studies demonstrated that plasma IL-17 levels were comparable between patients and controls (7, 10) . Keeping in mind that Th1 cytokines suppress Th17 development (3), our findings might be explained, at least in part, by the previous documented elevated Th1 response in ITP patients (11) . Furthermore, experimental evidence demonstrated quantitative/qualitative defects of regulatory T cells (Tregs) in ITP patients (11) . In this view, the generation of Tregs and Th17 cells from naïve T cells was shown to be correlated and, depending on the availability of IL-6, the balance between Tregs and Th17 cells could be shifted (12) . However, our results do not 
